BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 21415308)

  • 1. Bcl-xL is a dominant antiapoptotic protein that inhibits homoharringtonine-induced apoptosis in leukemia cells.
    Yin S; Wang R; Zhou F; Zhang H; Jing Y
    Mol Pharmacol; 2011 Jun; 79(6):1072-83. PubMed ID: 21415308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Homoharringtonine affects the JAK2-STAT5 signal pathway through alteration of protein tyrosine kinase phosphorylation in acute myeloid leukemia cells.
    Tong H; Ren Y; Zhang F; Jin J
    Eur J Haematol; 2008 Oct; 81(4):259-66. PubMed ID: 18616510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between survivin mRNA expression and homoharringtonine induced apoptosis of malignant hematopoietic cells.
    Cai Z; Bao HY; Lin MF
    Chin Med J (Engl); 2005 Apr; 118(7):548-54. PubMed ID: 15820085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Homoharringtonine mediates myeloid cell apoptosis via upregulation of pro-apoptotic bax and inducing caspase-3-mediated cleavage of poly(ADP-ribose) polymerase (PARP).
    Yinjun L; Jie J; Weilai X; Xiangming T
    Am J Hematol; 2004 Jul; 76(3):199-204. PubMed ID: 15224352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bcl-xL overexpression inhibits progression of molecular events leading to paclitaxel-induced apoptosis of human acute myeloid leukemia HL-60 cells.
    Ibrado AM; Liu L; Bhalla K
    Cancer Res; 1997 Mar; 57(6):1109-15. PubMed ID: 9067280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enforced expression of Bcl-XS induces differentiation and sensitizes chronic myelogenous leukemia-blast crisis K562 cells to 1-beta-D-arabinofuranosylcytosine-mediated differentiation and apoptosis.
    Ray S; Bullock G; Nuñez G; Tang C; Ibrado AM; Huang Y; Bhalla K
    Cell Growth Differ; 1996 Dec; 7(12):1617-23. PubMed ID: 8959329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucosamine sulfate-induced apoptosis in chronic myelogenous leukemia K562 cells is associated with translocation of cathepsin D and downregulation of Bcl-xL.
    Wang Z; Liang R; Huang GS; Piao Y; Zhang YQ; Wang AQ; Dong BX; Feng JL; Yang GR; Guo Y
    Apoptosis; 2006 Oct; 11(10):1851-60. PubMed ID: 16850161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "Loop" domain is necessary for taxol-induced mobility shift and phosphorylation of Bcl-2 as well as for inhibiting taxol-induced cytosolic accumulation of cytochrome c and apoptosis.
    Fang G; Chang BS; Kim CN; Perkins C; Thompson CB; Bhalla KN
    Cancer Res; 1998 Aug; 58(15):3202-8. PubMed ID: 9699642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of apoptosis by homoharringtonine in G1 phase human chronic myeloid leukemic cells.
    Mai WY; Lin MF
    Chin Med J (Engl); 2005 Mar; 118(6):487-92. PubMed ID: 15788130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Taxol and estramustine-induced modulation of human prostate cancer cell apoptosis via alteration in bcl-xL and bak expression.
    Liu QY; Stein CA
    Clin Cancer Res; 1997 Nov; 3(11):2039-46. PubMed ID: 9815595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myeloperoxidase expression as a potential determinant of parthenolide-induced apoptosis in leukemia bulk and leukemia stem cells.
    Kim YR; Eom JI; Kim SJ; Jeung HK; Cheong JW; Kim JS; Min YH
    J Pharmacol Exp Ther; 2010 Nov; 335(2):389-400. PubMed ID: 20699435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BAX/BCL-XL gene expression ratio inversely correlates with disease progression in chronic myeloid leukemia.
    Gonzalez MS; De Brasi CD; Bianchini M; Gargallo P; Moiraghi B; Bengió R; Larripa IB
    Blood Cells Mol Dis; 2010 Oct; 45(3):192-6. PubMed ID: 20728382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apoptosis induced by DNA primase inhibitor 3,3'-diethyl-9-methylthia-carbocyanine iodide in human leukemia HL-60 cells.
    Li ZM; Jiang WQ; Guan ZZ; Zhu XF; Zhou JM; Xie BF; Feng GK; Zhu ZY; Liu ZC
    Yao Xue Xue Bao; 2006 Oct; 41(10):978-84. PubMed ID: 17184117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of bcl-2 or bcl-XL fails to inhibit apoptosis mediated by a novel retinoid.
    Fontana JA; Sun RJ; Rishi AK; Dawson MI; Ordónez JV; Zhang Y; Tschang SH; Bhalla K; Han Z; Wyche J; Poirer G; Sheikh MS; Shroot B; Reichert U
    Oncol Res; 1998; 10(6):313-24. PubMed ID: 9848102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mcl-1, an early-induction molecule, modulates activin A-induced apoptosis and differentiation of CML cells.
    Fukuchi Y; Kizaki M; Yamato K; Kawamura C; Umezawa A; Hata Ji ; Nishihara T; Ikeda Y
    Oncogene; 2001 Feb; 20(6):704-13. PubMed ID: 11314004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of Bcl-2 or Bcl-xL inhibits Ara-C-induced CPP32/Yama protease activity and apoptosis of human acute myelogenous leukemia HL-60 cells.
    Ibrado AM; Huang Y; Fang G; Liu L; Bhalla K
    Cancer Res; 1996 Oct; 56(20):4743-8. PubMed ID: 8840993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Homoharringtonine suppresses imatinib resistance via the Bcl-6/p53 pathway in chronic myeloid leukemia cell lines.
    Wang Q; Ding W; Ding Y; Ma J; Qian Z; Shao J; Li Y
    Oncotarget; 2017 Jun; 8(23):37594-37604. PubMed ID: 28410239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bcl-xL overexpression inhibits taxol-induced Yama protease activity and apoptosis.
    Ibrado AM; Huang Y; Fang G; Bhalla K
    Cell Growth Differ; 1996 Aug; 7(8):1087-94. PubMed ID: 8853905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early down-regulation of Bcl-xL expression during megakaryocytic differentiation of thrombopoietin-induced CD34+ bone marrow cells in essential thrombocythemia.
    Zhang L; Zhao H; Sun A; Lu S; Liu B; Tang F; Feng Y; Zhao L; Yang R; Han ZC
    Haematologica; 2004 Oct; 89(10):1199-206. PubMed ID: 15477204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiapoptotic action of 1,25-dihydroxyvitamin D3 is associated with increased mitochondrial MCL-1 and RAF-1 proteins and reduced release of cytochrome c.
    Wang X; Studzinski GP
    Exp Cell Res; 1997 Aug; 235(1):210-7. PubMed ID: 9281370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.